Ezetimibe, Niemann-Pick C1 like 1 inhibitor, modulates hepatic phospholipid metabolism to alleviate fat accumulation
BackgroundEzetimibe, which lowers cholesterol by blocking the intestinal cholesterol transporter Niemann-Pick C1 like 1, is reported to reduce hepatic steatosis in humans and animals. Here, we demonstrate the changes in hepatic metabolites and lipids and explain the underlying mechanism of ezetimibe...
Saved in:
Main Authors: | Hyekyung Yang (Author), Dong Ho Suh (Author), Eun Sung Jung (Author), Yoonjin Lee (Author), Kwang-Hyeon Liu (Author), In-Gu Do (Author), Choong Hwan Lee (Author), Cheol-Young Park (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk Prediction for Niemann-Pick Disease
by: J Gordon Millichap
Published: (2012) -
Niemann-Pick Disease Type C
by: J Gordon Millichap
Published: (1989) -
Niemann-Pick Disease: Seven Questions about it
by: Nato D. Vashakmadze, et al.
Published: (2023) -
Advances in research on potential therapeutic approaches for Niemann-Pick C1 disease
by: Caifeng Zhang, et al.
Published: (2024) -
Enfermedad de Niemann-Pick: un enfoque global
by: Diana Villamandos García, et al.
Published: (2014)